You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Psychiatry, hypobetalipoproteinemia, LDL-Cholesterol

Showing 1 - 25 of 3,341
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Familial Hypobetalipoproteinemia Trial in Nantes (Psychiatric population)

Completed
  • Familial Hypobetalipoproteinemia
  • Psychiatric population
  • Nantes, France
    Nantes University Hospital Nantes
Sep 15, 2021

Familial Hypobetalipoproteinemia, Familial Hypobetalipoproteinemia - Heterozygous Form Trial (Administration of deuterated

Not yet recruiting
  • Familial Hypobetalipoproteinemia
  • Familial Hypobetalipoproteinemia - Heterozygous Form
  • Administration of deuterated compounds for kinetic study
  • (no location specified)
Oct 5, 2022

Healthy Trial (Mango, vanilla wafers)

Not yet recruiting
  • Healthy
  • Mango
  • vanilla wafers
  • (no location specified)
Sep 7, 2023

Cognitive Function in Patients Treated With PCSK9 Inhibitors

Completed
  • Cognitive Function
  • +2 more
  • PCSK9 inhibitor
  • Cee, A Coruña, Spain
  • +11 more
Jan 13, 2023

Hypobetalipoproteinemia Trial in Nantes (hypobetalipoproteinemia genetic and genotypic screening)

Completed
  • Hypobetalipoproteinemia
  • hypobetalipoproteinemia genetic and genotypic screening
  • Nantes, France
    CHU de Nantes
Feb 22, 2022

Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease Risk Equivelents, Elevated Low Density

Active, not recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Sale, Cheshire, United Kingdom
  • +16 more
Jan 20, 2023

Above Optimal Plasma LDL Concentrations Trial in Winnipeg, Toronto (muffin)

Active, not recruiting
  • Above Optimal Plasma LDL Concentrations
  • muffin
  • Winnipeg, Manitoba, Canada
  • +1 more
Oct 24, 2022

Hypercholesterolemia, Primary Prevention Trial in Sao Paulo (Phytosterol supplements)

Completed
  • Hypercholesterolemia
  • Primary Prevention
  • Phytosterol supplements
  • Sao Paulo, Other, Brazil
  • +1 more
Nov 9, 2023

Cardiovascular Disease Trial in Seoul (Intensive targeting group, Conventional therapy group)

Recruiting
  • Cardiovascular Disease
  • Intensive targeting group
  • Conventional therapy group
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Oct 7, 2022

Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • (no location specified)
Aug 22, 2023

Hyperlipidemic Trial (SHR-1918, SHR-1918 )

Not yet recruiting
  • Hyperlipidemic
  • (no location specified)
Oct 26, 2023

Hypercholesterolemia Trial in Clermont-ferrand, Clermont-Ferrand, Durtol (LIMICOL, PLACEBO)

Completed
  • Hypercholesterolemia
  • LIMICOL
  • PLACEBO
  • Clermont-ferrand, France
  • +3 more
Feb 28, 2023

Atheroscleroses, Coronary Trial in Seoul (Rosuvastatin and Ezetimibe, Rosuvastatin)

Active, not recruiting
  • Atheroscleroses, Coronary
  • Seoul, Korea, Republic of
  • +1 more
Oct 1, 2022

ASCVD, Coronary Artery Calcification Trial (Notification of patients and clinicians)

Not yet recruiting
  • ASCVD
  • Coronary Artery Calcification
  • Notification of patients and clinicians
  • (no location specified)
May 5, 2023

Hyper-low-density Lipoprotein (LDL) Cholesterolemia Trial in Izumisano-shi (180mg of ETC-1002(bempedoic acid), Placebo)

Recruiting
  • Hyper-low-density Lipoprotein (LDL) Cholesterolemia
  • 180mg of ETC-1002(bempedoic acid)
  • Placebo
  • Izumisano-shi, Japan
    Rinku General Medical Center
Jan 4, 2023

Abdominal Aortic Aneurysm Trial (Evolocumab, Placebo)

Not yet recruiting
  • Abdominal Aortic Aneurysm
  • (no location specified)
Oct 12, 2023

Acute Coronary Syndrome Trial in United States (Inclisiran)

Recruiting
  • Acute Coronary Syndrome
  • Huntsville, Alabama
  • +77 more
Jan 13, 2023

Dyslipidemias, Stroke, Acute Ischemic Trial in Ansan, Seoul (combination of high-dose rosuvastatin and ezetimibe, high-dose

Recruiting
  • Dyslipidemias
  • Stroke, Acute Ischemic
  • combination of high-dose rosuvastatin and ezetimibe
  • high-dose rosuvastatin single administration
  • Ansan, Gyeonggi-do, Korea, Republic of
  • +2 more
May 22, 2023

Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

Recruiting
  • Coronary Artery Disease
  • Dyslipidemias
  • a high dose of statin/ezetimib
  • Yongin, Gyeonggi-do, Korea, Republic of
    Yongin Severance Hospital
Jun 14, 2023

Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)

Not yet recruiting
  • Primary Hypercholesterolemia or Mixed Dyslipidemia
  • (no location specified)
May 24, 2023

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other

Not yet recruiting
  • To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
  • Combination for Subgroup High LDL-c Patients With Other Comorbidities
  • RN0191 INJECTION
  • (no location specified)
Jun 14, 2023

Categories and Attaining LDL-C Targets in Middle Eastern Adults

Not yet recruiting
  • Atherosclerotic Cardiovascular Risk
  • Low-density-lipoprotein (LDL) Cholesterol
    • (no location specified)
    Feb 16, 2023

    Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

    Not yet recruiting
    • Hypercholesterolemia
    • Familial Hypercholesterolemia
    • (no location specified)
    Jul 10, 2023

    LDL-cholesterol Trial in Jena (statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran)

    Recruiting
    • LDL-cholesterol
    • statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
    • Jena, Thuringia, Germany
      University Hospital Jena
    Oct 17, 2022